Falsey, Ann R.
Maggi, Stefania
Biering-Sørensen, Tor
Funding for this research was provided by:
Sanofi
Article History
Received: 4 October 2023
Accepted: 26 January 2024
First Online: 14 March 2024
Declarations
:
: Ann Falsey has received research funding from Janssen, Merck, Pfizer, Moderna, CyanVac, VaxCo, and Biofire Diagnostics, and consulting fees for Sanofi-Pasteur, GSK, and ADMA Biologics. Stefania Maggi has received research grants and personal fees as an advisory board member and/or speaker from: GSK, Pfizer, Sanofi, Takeda, Viatris, Janssen, Novavax, and Moderna. Tor Biering-Sørensen has received research grants from Sanofi-Pasteur, GSK, Novo Nordisk, AstraZeneca, Boston Scientific and GE Healthcare, consulting fees from Novo Nordisk, IQVIA, Parexel, Amgen, CSL Seqirus, GSK and Sanofi-Pasteur, and lecture fees from Bayer, Novartis, Sanofi-Pasteur, GE healthcare and GSK.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.